Grants and Contributions:
Title:
2425-HQ-000035
Agreement Number:
2425-HQ-000035
Agreement Value:
$39,726,525.00
Agreement Date:
Mar 7, 2025 - Mar 31, 2027
Description:
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Organization:
Health Canada
Expected Results:
Improved collaboration across provincial/territorial drug plans related to drugs for rare decisions decision-making.
Canadians with rare diseases have better access to screening and diagnostic services they need.
Location:
Halifax, Nova Scotia, CA B3J 2R8
Reference Number:
271-2024-2025-Q4-00115
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
125030429
Recipient Type:
Government
Recipient's Legal Name:
Government of Nova Scotia - Department of Health and Wellness
Program:
National Strategy for Drugs for Rare Diseases Program
Program Purpose:
Canadian Health Systems and Programs